BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?
BioCryst Pharmaceuticals, Inc.
Biocryst Pharmaceuticals Inc (BCRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 15,827,186 | $158,271,860 | 1.38% | |
| 2. | Deerfield Management James E. Flynn | 15,096,403 | $150,964,030 | +1% | 1.57% |
| 3. | Perceptive Advisors Joseph Edelman | 10,308,888 | $103,088,880 | +39% | 1.55% |
| 4. | Vestal Point Capital Ryan Wilder | 8,300,000 | $83,000,000 | +19% | 1.94% |
| 5. | Millennium Management Israel Englander | 3,394,729 | $33,947,290 | +1709% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.36 | 7,861 | $49,995.96 | 44,951 | 2024-05-30 | Filing | |
| $6.40 | 2,500 | $16,000.00 | 2,500 | 2024-05-24 | Filing | |
| $6.38 | 5,000 | $31,900.00 | 86,818 | 2024-05-20 | Filing | |
| $6.25 | 15,000 | $93,750.00 | 66,997 | 2024-05-20 | Filing | |
| $5.57 | 36,300 | $202,191.00 | 266,744 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.97 | 11,180 | $100,284.60 | 31,252 | 2026-05-18 | Filing | |
| $9.54 | 62,500 | $596,250.00 | 400,703 | 2026-05-13 | Filing | |
| $10.11 | 49,933 | $504,822.63 | 65,352 | 2026-03-20 | Filing | |
| $9.15 | 150,000 | $1,372,500.00 | 400,703 | 2026-03-16 | Filing | |
| $7.65 | 21,773 | $166,563.45 | 398,751 | 2025-12-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 449,082 | $3,740,853 | 0% | |
| 2. | 434,114 | $3,616,170 | 0.06% | |
| 3. | 362,878 | $3,022,777 | 0.13% | |
| 4. | 304,328 | $2,535,052 | 0.55% | |
| 5. | 114,525 | $953,993 | 0.03% |
News See All
10 Best Growth Stocks Under $50 to Buy Now
A Record Market Is Leaving Many Stocks Behind Growth stocks under $50 offer investors a way to buy shares in companies expanding their businesses without a high per-share purchase price.
10 Best Aggressive Growth Stocks to Buy According to Wall Street Analysts
Rapid revenue growth can change a company's scale before its share price reflects a mature business.
Claude AI Just Bought These 2 Pharma Stocks
Note: The stock trades discussed in this article come from AI Finance Labs, an investment experiment that operates publicly viewable portfolios directed by models including Claude, ChatGPT, Grok and DeepSeek...
Is BioCryst's (BCRX) Newest Approval Bigger Than It Looks?
Beneath the headline-driven sentiment of biotech investing lies the true engine of value creation: portfolio durability, capital efficiency, and sustainable revenue compounding.
BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs
On August 28, 2026, CNBC reported that BioCryst Pharmaceuticals, Inc.
3 Best Stocks With 140%+ Upside to Buy This Week, According to Analysts
Analysts see major upside in some stocks this week, with three names showing more than 140% potential gains based on current price targets. While e...
Wall Street's 76 Biggest Earnings Winners
Latest data from financial data firm FactSet said an earnings per share growth of 15 percent or more is already considered an unusually strong result rather than a normal earnings outcome.
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on BCRX.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2026 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2026 Earnings Call Transcript May 6, 2026BioCryst Pharmaceuticals, Inc. misses on earnings expectations.
Hedge Fund Resource Center